Publikationen, an denen er mitarbeitet Francisco Alameda Quitllet (9)

2019

  1. Addition of IMP3 to L1CAM for discrimination between low- and high-grade endometrial carcinomas: a European Network for Individualised Treatment of Endometrial Cancer collaboration study

    Human Pathology, Vol. 89, pp. 90-98

2018

  1. Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study

    International Journal of Gynecological Cancer, Vol. 28, Núm. 3, pp. 514-523

2016

  1. L1CAM expression in endometrial carcinomas: An ENITEC collaboration study

    British Journal of Cancer, Vol. 115, Núm. 6, pp. 716-724

2007

  1. ERM/ETV5 up-regulation plays a role during myometrial infiltration through matrix metalloproteinase-2 activation in endometrial cancer

    Cancer Research, Vol. 67, Núm. 14, pp. 6753-6759

  2. Molecular determinants of invasion in endometrial cancer

    Clinical and Translational Oncology, Vol. 9, Núm. 5, pp. 272-277

2006

  1. Molecular pathology of endometrial carcinoma: Transcriptional signature in endometrioid tumors

    Histology and Histopathology, Vol. 21, Núm. 1-3, pp. 197-204

  2. The up-regulation profiles of p21WAF1/CIP1 and RUNX1/AML1 correlate with myometrial infiltration in endometrioid endometrial carcinoma

    Human Pathology, Vol. 37, Núm. 8, pp. 1050-1057

2005

  1. Up-regulation of ERM/ETV5 correlates with the degree of myometrial infiltration in endometrioid endometrial carcinoma

    Journal of Pathology, Vol. 207, Núm. 4, pp. 422-429

2004

  1. A differential gene expression profile reveals overexpression of RUNX1/AML1 in invasive endometrioid carcinoma

    Cancer Research, Vol. 64, Núm. 24, pp. 8846-8853